I-MED Pharma to Bring Clinically Proven E>Eye IRPL® Technology to Canada
Montreal, May 24, 2018 (Globe Newswire) – I-MED Pharma Inc., a Canadian company specializing in dry eye diagnosis and management, is pleased to announce the
Montreal, May 24, 2018 (Globe Newswire) – I-MED Pharma Inc., a Canadian company specializing in dry eye diagnosis and management, is pleased to announce the
Montreal, April 3, 2018 (Globe Newswire) – I-MED Pharma Inc., a Canadian Company specializing in dry eye diagnosis and management, is pleased to announce receiving
Montreal, February 20, 2018 (GLOBE NEWSWIRE) – On February 14th TearLab issued a press release indicating it will appeal after its defeat in a patent
Montreal, February 13, 2018 (GLOBE NEWSWIRE) – I-MED Pharma Inc., announced today that TearLab’s efforts to keep the I-PEN® Osmolarity System off the market proved
Montreal, January 8, 2018 (Globe Newswire) – I-MED Pharma Inc., a Canadian company specializing in dry eye diagnosis and management, is pleased to announce the
MONTREAL, January 8, 2018 (GLOBE NEWSWIRE) – I-MED Pharma, Inc., a Canadian company specializing in dry eye diagnosis and management, announced today the signing of
Get ready for new website features coming soon! The e-commerce portion of this site is currently in a testing phase with limited clients.
Osdcare.com is still in effect for the majority of our clinics at this time.